[HTML][HTML] The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation

Z Bai, Y Cao, W Liu, J Li - Viruses, 2021 - mdpi.com
The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the world
is still expanding. Thus, there is an urgent need to better understand this novel virus and find …

Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19

B Böger, MM Fachi, RO Vilhena, AF Cobre… - American journal of …, 2021 - Elsevier
Objective To collate the evidence on the accuracy parameters of all available diagnostic
methods for detecting SARS-CoV-2. Methods A systematic review with meta-analysis was …

Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey

KO Kwok, KK Li, WI Wei, A Tang, SYS Wong… - International journal of …, 2021 - Elsevier
Background A healthy healthcare system requires healthy healthcare workers. Protecting
healthcare workers including nurses against COVID-19 is crucial, and vaccination could be …

[HTML][HTML] Overview of immune response during SARS-CoV-2 infection: lessons from the past

VK Shah, P Firmal, A Alam, D Ganguly… - Frontiers in …, 2020 - frontiersin.org
After the 1918 flu pandemic, the world is again facing a similar situation. However, the
advancement in medical science has made it possible to identify that the novel infectious …

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

ML Bastos, G Tavaziva, SK Abidi, JR Campbell… - bmj, 2020 - bmj.com
Objective To determine the diagnostic accuracy of serological tests for coronavirus disease-
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …

[HTML][HTML] Antibody responses to SARS-CoV-2 in patients with COVID-19

QX Long, BZ Liu, HJ Deng, GC Wu, K Deng, YK Chen… - Nature medicine, 2020 - nature.com
We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …

The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

L Premkumar, B Segovia-Chumbez, R Jadi… - Science …, 2020 - science.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in
late 2019 is responsible for a pandemic of severe respiratory illness. People infected with …

[HTML][HTML] A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

AT Huang, B Garcia-Carreras, MDT Hitchings… - Nature …, 2020 - nature.com
Many public health responses and modeled scenarios for COVID-19 outbreaks caused by
SARS-CoV-2 assume that infection results in an immune response that protects individuals …

[HTML][HTML] Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)

DG Ahn, HJ Shin, MH Kim, S Lee, HS Kim… - … of microbiology and …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …

[HTML][HTML] Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients

NMA Okba, MA Müller, W Li, C Wang… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …